Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research Units
Equipment
Projects
Research output
Prizes
Activities
Press / Media
Search by expertise, name or affiliation
A phase III randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of PRM-151 in patients with idiopathic pulmonary fibrosis
Li, Xun
(Primary Chief Investigator (PCI))
Medicine Monash Health
Project
:
Research
Overview
Project Details
Status
Active
Effective start/end date
9/08/21
→
8/08/26
View all
View less
Keywords
phase 3 study
treatment efficacy
treatment safety
pulmonary fibrosis